129 related articles for article (PubMed ID: 1832912)
1. Comparison between single saturating dose ligand binding assay and enzyme immunoassay for low-salt extractable oestrogen and progesterone receptors in breast cancer: a multicentre study.
Gion M; Dittadi R; Leon AE; Bruscagnin G; Pelizzola D; Giovannini G; Giganti M; Messeri G; Quercioli M; Flamini E
Eur J Cancer; 1991; 27(8):996-1002. PubMed ID: 1832912
[TBL] [Abstract][Full Text] [Related]
2. Steroid receptor measurement in breast cancers: comparison between ligand binding and enzyme-immunoassay in cytosolic and nuclear extracts.
Luqmani YA; Temmim L; Memon A; Ali MA; Parkar AH
Int J Cancer; 1997 May; 71(4):526-38. PubMed ID: 9178804
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and progesterone receptors in breast cancer: comparison between enzyme immunoassay and computer-assisted image analysis of immunocytochemical assay.
Cavaliere A; Bucciarelli E; Sidoni A; Bianchi G; Pietropaoli N; Ludovini V; Vitali R
Cytometry; 1996 Sep; 26(3):204-8. PubMed ID: 8889392
[TBL] [Abstract][Full Text] [Related]
4. Significance of the 8S complex in oestrogen receptor recognition.
Marsigliante S; Puddefoot JR; Barker S; Goode AW; Vinson GP
J Steroid Biochem Mol Biol; 1991 Nov; 39(5A):703-11. PubMed ID: 1958507
[TBL] [Abstract][Full Text] [Related]
5. Steroid receptor distribution in 47,892 breast cancers. A collaborative study of 7 European laboratories. The EORTC Receptor Study Group.
Romain S; Lainé Bidron C; Martin PM; Magdelenat H
Eur J Cancer; 1995; 31A(3):411-7. PubMed ID: 7786610
[TBL] [Abstract][Full Text] [Related]
6. Detection of different estrogen receptor forms in breast cancer cytosol by enzyme immunoassay.
Dittadi R; Meo S; Amoroso B; Gion M
Cancer Res; 1997 Mar; 57(6):1066-72. PubMed ID: 9067273
[TBL] [Abstract][Full Text] [Related]
7. Detection of steroid receptors in breast cancer: relationship between EIA and IHC methods.
Lerma E; Esqué C; Peiró G; Mora J; Cerdá I; Prat J
Scand J Clin Lab Invest; 1994 Dec; 54(8):591-4. PubMed ID: 7709160
[TBL] [Abstract][Full Text] [Related]
8. Discrepancies between antibody (EIA) and saturation analysis of oestrogen receptor content in breast tumour samples.
Marsigliante S; Puddefoot JR; Barker S; Gledhill J; Vinson GP
J Steroid Biochem Mol Biol; 1990 Dec; 37(5):643-8. PubMed ID: 2278849
[TBL] [Abstract][Full Text] [Related]
9. Comparison of enzyme immunoassay with dextran-coated charcoal method in the determination of progesterone receptor in breast cancer cytosols.
Noguchi S; Miyauchi K; Imaoka S; Koyama H; Iwanaga T
Eur J Cancer Clin Oncol; 1988 Nov; 24(11):1715-9. PubMed ID: 3061826
[TBL] [Abstract][Full Text] [Related]
10. Estrogen and progesterone receptors in breast cancer microsamples simultaneously quantified by enzyme-ligand immunoassay.
Krambovitis E; Hatzidakis G; Hatzoglou A; Romain S; Durand A; Stefanakis A; Castanas E
Clin Chem; 1995 Jan; 41(1):48-53. PubMed ID: 7813080
[TBL] [Abstract][Full Text] [Related]
11. Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay.
Saccani Jotti G; Johnston SR; Salter J; Detre S; Dowsett M
J Clin Pathol; 1994 Oct; 47(10):900-5. PubMed ID: 7962603
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor determination in endometrial carcinoma: ligand binding assay versus enzyme immunoassay.
Nyholm HC; Nielsen AL; Lyndrup J; Greene GL; Thorpe SM
Anticancer Res; 1995; 15(2):649-54. PubMed ID: 7763051
[TBL] [Abstract][Full Text] [Related]
13. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.
Konecny G; Pauletti G; Pegram M; Untch M; Dandekar S; Aguilar Z; Wilson C; Rong HM; Bauerfeind I; Felber M; Wang HJ; Beryt M; Seshadri R; Hepp H; Slamon DJ
J Natl Cancer Inst; 2003 Jan; 95(2):142-53. PubMed ID: 12529347
[TBL] [Abstract][Full Text] [Related]
14. [Measurement of estrogen receptor and progesterone receptor in human endometrium and endometrial carcinoma].
Itoh E
Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):812-20. PubMed ID: 2196312
[TBL] [Abstract][Full Text] [Related]
15. Quantitative monoclonal antibody determination of estrogen and progesterone receptors in human breast cancer: correlation with the radioligand method.
Jarque F; Lluch A; Vizcarra E; Muñoz M; Alberola V; Garciá-Conde J
Oncology; 1994; 51(5):435-9. PubMed ID: 8052485
[TBL] [Abstract][Full Text] [Related]
16. Relationship between radioligand binding assay, immunoenzyme assay and immunohistochemical assay for estrogen receptors in human breast cancer and association with tumor differentiation.
Andersen J; Bentzen SM; Poulsen HS
Eur J Cancer Clin Oncol; 1988 Mar; 24(3):377-84. PubMed ID: 3289941
[TBL] [Abstract][Full Text] [Related]
17. [Inconsistency in quantitation of estrogen receptor and progesterone receptor with dextran charcoal method and enzyme immunoassay].
Morimoto K; Hasuma T; Koh M; Ohtani S; Kinoshita H
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1597-605. PubMed ID: 12355945
[TBL] [Abstract][Full Text] [Related]
18. Transcriptionally active non-ligand binding oestrogen receptors in breast cancer.
Marsigliante S; Greco S; Biscozzo L; Barker S; Baker V; Giuseppe L; Vinson GP; Storelli C
Cancer Lett; 1992 Oct; 66(3):183-91. PubMed ID: 1451100
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
[TBL] [Abstract][Full Text] [Related]
20. Reverse transcription-polymerase chain reaction (RT-PCR) assays of estrogen and progesterone receptors in breast cancer.
Chevillard S; Müller A; Levalois C; Lainé-Bidron C; Vielh P; Magdelénat H
Breast Cancer Res Treat; 1996; 41(1):81-9. PubMed ID: 8932879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
